ArticleBlood advances2021

Letermovir prophylaxis in T-cell-depleted transplants: breakthrough and rebound infections in the postmarketing setting.

Maria A V Marzolini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.